Walgreens Boots Alliance, Inc.
WBADelisted- Industry
- Retail-Drug Stores and Proprietary Stores
- SEC CIK
- 0001618921
Walgreens Boots Alliance, Inc. was delisted in 2025; its insiders filed their last Form 4 on Aug 28, 2025; 808 institutions reported holding it in 13F filings for Q2 2025, worth $6.28B in total; Soros Fund Management was the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Walgreens Boots Alliance, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Walgreens Boots Alliance, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Wentworth Timothy C | Chief Executive Officer | 0 | Aug 28, 2025 | 0 |
| Pessina Stefano | Executive Chairman of Board | 0Indirect | Aug 28, 2025 | 0 |
| Burger Elizabeth | EVP, Global Chief HR Officer | 0 | Aug 28, 2025 | 0 |
| Barra Ornella | Chief Operating Officer, Int'l | 0Indirect | Aug 28, 2025 | 0 |
| Minnix Lanesha | EVP, Global CLO & Corp. Sec. | 0 | Aug 28, 2025 | 0 |
| Brown Tracey D | EVP, Pres., Walgreens Retail | 0 | Aug 28, 2025 | 0 |
| Mahajan Manmohan | EVP and Global CFO | 0 | Aug 28, 2025 | 0 |
| Gates Richard P. | SVP, Chief Pharmacy Officer | 0 | Aug 28, 2025 | 0 |
| Heckman Todd | SVP, Global Controller and CAO | 0 | Aug 28, 2025 | 0 |
| Fabbri Beth Amber L. | SVP Chief Corp Affairs Officer | 0 | Aug 28, 2025 | 0 |
| Langowksi Mary | EVP, President U.S. Healthcare | 0 | Aug 28, 2025 | 0 |
| Graham Ginger L | Director | – | Aug 15, 2025 | 0 |
| Jarrett Valerie B | Director | 4,456 | Aug 15, 2025 | 0 |
| Schlichting Nancy M | Director | 37,961 | Aug 15, 2025 | 0 |
| Lederer John Anthony | Director | – | Aug 15, 2025 | 0 |
| Hanson Bryan C | Director | 47,655 | Aug 15, 2025 | 0 |
| Babiak Janice M. | Director | – | Aug 15, 2025 | 0 |
| Polen Thomas E Jr | Director | 28,269 | Aug 15, 2025 | 0 |
| Huffines Robert Luther | Director | – | Aug 15, 2025 | 0 |
| Shrank William H | Director | 3,523 | Aug 15, 2025 | 0 |
| Bhandari Inderpal S | Director | 3,000 | Aug 15, 2025 | 0 |
| Sample Neal J. | EVP, Chief Information Officer | 379,683 | Nov 5, 2024 | 0 |
| Murphy Dominic | Director | – | Jan 29, 2024 | 0 |
| Driscoll John Patrick | EVP, Pres. U.S. Healthcare | 272,204 | Nov 3, 2023 | 0 |
| May Holly | EVP, Global Chief HR Officer | 188,829 | Nov 3, 2023 | 0 |
| Gray Danielle | EVP and Global CLO | 210,301 | Nov 3, 2023 | 0 |
| Ban Kevin M. | EVP, Chief Medical Officer | 113,930 | Nov 3, 2023 | 0 |
| Kehoe James | EVP and Global CFO | 268,403 | May 3, 2023 | 0 |
| Brewer Rosalind G | CEO | 369,945 | Mar 31, 2023 | 0 |
| Foote William C | Director | – | Nov 3, 2022 | 0 |
| Shulman Steven J | Director | 25,136 | Nov 3, 2022 | 0 |
| Cooper Henry Lee | EVP, Pres. Walgreens Pharmacy | 32,563 | Nov 3, 2022 | 0 |
| Standley John T | EVP and President, Walgreen Co | 89,227 | Oct 28, 2022 | 0 |
| Brailer David J | Director | – | Jul 15, 2022 | 0 |
| Skinner James A | Director | 656,782 | Nov 3, 2021 | 0 |
| Almeida Jose E | Director | 17,581 | Nov 3, 2021 | 0 |
| Pagni Marco Patrick Anthony | EVP, Global CAO and GC | 32,966 | Sep 2, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2025 (view filing) | Apr 27 | 2 days | Pessina StefanoExecutive Chairman of Board | SSaleCommon Stock, par value $0.01 per share | −832.3K | $11.01 | −$9.16M | −55.9%657.3K after | |
| Apr 29, 2025 (view filing) | Apr 27 | 2 days | Pessina StefanoExecutive Chairman of Board | PPurchaseCommon Stock, par value $0.01 per share | +832.3K | $11.01 | +$9.16M | +0.6%145.6M after | |
| Apr 15, 2024 (view filing) | Apr 11 | 4 days | Bhandari Inderpal SDirector | PPurchase | +3.00K | $18.05 | +$54.1K | New position3.00K after | |
| Apr 2, 2024 (view filing) | Apr 2 | Same day | Mahajan ManmohanEVP and Global CFO | PPurchase | +6.00K | $19.38 | +$116.3K | +3.7%167.0K after | |
| Jan 31, 2024 (view filing) | Jan 29 | 2 days | Jarrett Valerie BDirector | PPurchase | +4.46K | $22.44 | +$100.0K | New position4.46K after | |
| Jan 18, 2024 (view filing) | Jan 16 | 2 days | Schlichting Nancy MDirector | SSale | −15.2K | $23.05 | −$350.6K | −100.0%0 after | |
| Jan 8, 2024 (view filing) | Jan 5 | 3 days | Wentworth Timothy CChief Executive Officer | PPurchase | +10.0K | $24.22 | +$242.2K | +1.7%585.1K after | |
| Nov 14, 2023 (view filing) | Nov 10 | 4 days | Gates Richard P.SVP, Chief Pharmacy Officer | SSale | −1.00K | $20.45 | −$20.4K | −1.3%73.9K after | |
| Jul 5, 2023 (view filing) | Jun 30 | 5 days | Driscoll John PatrickEVP, Pres. U.S. Healthcare | PPurchase | +5.17K | $28.42 | +$147.0K | +9.6%59.0K after | |
| Mar 31, 2023 (view filing) | Mar 29 | 2 days | Brewer Rosalind GCEO | PPurchase | +10.0K | $33.95 | +$339.5K | +2.8%369.9K after | |
| Nov 22, 2022 (view filing) | Nov 18 | 4 days | Ban Kevin M.EVP, Chief Medical Officer | SSale | −10.3K | $40.19 | −$414.1K | −27.0%27.9K after | |
| Nov 21, 2022 (view filing) | Nov 17 | 4 days | Schlichting Nancy MDirector | SSale | −16.6K | $39.89 | −$661.0K | −75.0%5.51K after | |
| Nov 23, 2021 (view filing) | Nov 19 | 4 days | Schlichting Nancy MDirector | SSale | −2.73K | $47.16 | −$128.5K | −14.1%16.6K after |